We do not support your browser. Please take a moment and upgrade to the most recent version of Internet Explorer.
CTSI Directory
PROFILE SEARCH:
ADVANCED SEARCH

James A Mckinnell, M.D. [ Edit Your Profile ]

Work Email Address: dr.mckinnell@yahoo.com

Work Phone Number: (310) 222-3813

Mailing Address:
Harbor-UCLA Medl Cntr-Inf Dis
1000 W Carson St, Box 466
Torrance, CA 90509

Work
Harbor-UCLA Medical Center Assistant Professor, Harbor-UCLA Medical Center

Education:
Degrees:
M.D.

About

Dr. James A. McKinnell is an Infectious Disease specialist from Harbor-UCLA Medical Center and the Los Angeles Biomedical Research Institute. Dr. McKinnell’s research focuses on health outcomes as they relate to antibiotic utilization and infection. McKinnell has co-authored more than 20 publications including investigations on the impact of drug selection on healthcare outcomes, quality of care, and predictors of treatment failure for bacterial and fungal infections.\r\n\tDr. McKinnell received research support from the UCLA KL2 Translational Science Scholars award for his investigations of VRE bloodstream infections. Dr. McKinnell has developed electronic relationships between datasets and personal relationships between the various stakeholders of the clinical data systems including clinical databases, microbiology, anitbiotic utilization and health economic outcomes. \r\n

Publications
McKinnell James A, Huang Susan S, Eells Samantha J, Cui Eric, Miller Loren G, Quantifying the impact of extranasal testing of body sites for methicillin-resistant Staphylococcus aureus colonization at the time of hospital or intensive care unit admission. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America. 2013; 34(2): 161-70.
Whang Donald W, Miller Loren G, Partain Neil M, McKinnell James A, Systematic Review and Meta-Analysis of Linezolid versus Daptomycin for Treatment of Vancomycin-Resistant Enterococcal Blood Stream Infections. Antimicrobial agents and chemotherapy. 2013; .
McKinnell James A, Kunz Danielle F, Chamot Eric, Patel Mukesh, Shirley Rhett M, Moser Stephen A, Baddley John W, Pappas Peter G, Miller Loren G, Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America. 2012; 33(7): 718-24.
McKinnell J A, Cannella A P, Kunz D F, Hook E W, Moser S A, Miller L G, Baddley J W, Pappas P G, Pneumocystis pneumonia in hospitalized patients: a detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (HIV)-infected and HIV-uninfected persons. Transplant infectious disease : an official journal of the Transplantation Society. 2012; 14(5): 510-8.
Mishra Nagendra N, Liu George Y, Yeaman Michael R, Nast Cynthia C, Proctor Richard A, McKinnell James, Bayer Arnold S, Carotenoid-related alteration of cell membrane fluidity impacts Staphylococcus aureus susceptibility to host defense peptides. Antimicrobial agents and chemotherapy. 2011; 55(2): 526-31.
Seidl Kati, Bayer Arnold S, Fowler Vance G, McKinnell James A, Abdel Hady Wessam, Sakoulas George, Yeaman Michael R, Xiong Yan Q, Combinatorial phenotypic signatures distinguish persistent from resolving methicillin-resistant Staphylococcus aureus bacteremia isolates. Antimicrobial agents and chemotherapy. 2011; 55(2): 575-82.
Eells Samantha J, McKinnell James A, Miller Loren G, Daily cranberry prophylaxis to prevent recurrent urinary tract infections may be beneficial in some populations of women. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2011; 52(11): 1393-4; author reply 1394-5.
Miller Loren G, McKinnell James A, Vollmer Michael E, Spellberg Brad, Impact of methicillin-resistant Staphylococcus aureus prevalence among S. aureus isolates on surgical site infection risk after coronary artery bypass surgery. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America. 2011; 32(4): 342-50.
Mishra Nagendra N, McKinnell James, Yeaman Michael R, Rubio Aileen, Nast Cynthia C, Chen Liang, Kreiswirth Barry N, Bayer Arnold S, In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates. Antimicrobial agents and chemotherapy. 2011; 55(9): 4012-8.
Seidl Kati, Bayer Arnold S, McKinnell James A, Ellison Steven, Filler Scott G, Xiong Yan Q, In vitro endothelial cell damage is positively correlated with enhanced virulence and poor vancomycin responsiveness in experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Cellular microbiology. 2011; 13(10): 1530-41.
McKinnell James A, Stollenwerk Nicholas S, Jung Chin W, Miller Loren G, Nitrofurantoin compares favorably to recommended agents as empirical treatment of uncomplicated urinary tract infections in a decision and cost analysis. Mayo Clinic proceedings. Mayo Clinic. 2011; 86(6): 480-8.
McKinnell J A, Patel M, Shirley R M, Kunz D F, Moser S A, Baddley J W, Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents. Epidemiology and infection. 2011; 139(9): 1342-50.
McKinnell James A, Eells Samantha J, Wang Angel A, Miller Loren G, Simultaneous use of other antimicrobials may have influenced clinical outcomes. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2011; 52(10): 1279; author reply 1279-80.
McKinnell James A, Willig James H, Westfall Andrew O, Nevin Christa, Allison Jeroan J, Raper James L, Mugavero Michael J, Saag Michael S, Antiretroviral prescribing patterns in treatment-naïve patients in the United States. AIDS patient care and STDs. 2010; 24(2): 79-85.
McKinnell James A, Pappas Peter G, Blastomycosis: new insights into diagnosis, prevention, and treatment. Clinics in chest medicine. 2009; 30(2): 227-39, v.
McKinnell James A, Lin Hui-Yi, Nevin Christa N, Willig James H, McFarland Graeme, Genz Michael, Raper James L, DeLaitsch Lori L, Mrus Joseph M, Klaskala Winslow, Mugavero Michael J, Saag Michael S, Early virologic suppression with three-class experienced patients: 24-week effectiveness in the darunavir outcomes study. AIDS (London, England). 2009; 23(12): 1539-46.
McKinnell James A, Saag Michael S, Novel drug classes: entry inhibitors [enfuvirtide, chemokine (C-C motif) receptor 5 antagonists]. Current opinion in HIV and AIDS. 2009; 4(6): 513-7.
McKinnell James, Tayek John A, Short term treatment with clarithromycin resulting in colchicine-induced rhabdomyolysis. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 2009; 15(6): 303-5.
Winfree C J, Mack W J, Hoh D, King R, Ducruet A F, D'Ambrosio A L, Sughrue M E, McKinnell J, Connolly E S, Laser Doppler flowmetry in non-human primate stroke studies: model refinement for pre-clinical development of cerebroprotective strategies. Acta neurochirurgica. 2003; 145(12): 1105-10; discussion 1110.

Cite the Grant Number Trial Innovation Network Smart IRB